nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftibuten—Dermatitis—Pazopanib—kidney cancer	0.00191	0.00191	CcSEcCtD
Ceftibuten—Anorexia—Sunitinib—kidney cancer	0.0019	0.0019	CcSEcCtD
Ceftibuten—Agitation—Vincristine—kidney cancer	0.0019	0.0019	CcSEcCtD
Ceftibuten—Candida infection—Doxorubicin—kidney cancer	0.0019	0.0019	CcSEcCtD
Ceftibuten—Haemoglobin—Paclitaxel—kidney cancer	0.0019	0.0019	CcSEcCtD
Ceftibuten—Abdominal pain—Vinblastine—kidney cancer	0.0019	0.0019	CcSEcCtD
Ceftibuten—Headache—Pazopanib—kidney cancer	0.0019	0.0019	CcSEcCtD
Ceftibuten—Abdominal pain—Everolimus—kidney cancer	0.00189	0.00189	CcSEcCtD
Ceftibuten—Body temperature increased—Everolimus—kidney cancer	0.00189	0.00189	CcSEcCtD
Ceftibuten—Haemorrhage—Paclitaxel—kidney cancer	0.00189	0.00189	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Erlotinib—kidney cancer	0.00189	0.00189	CcSEcCtD
Ceftibuten—Vaginal infection—Doxorubicin—kidney cancer	0.00188	0.00188	CcSEcCtD
Ceftibuten—Aplastic anaemia—Doxorubicin—kidney cancer	0.00187	0.00187	CcSEcCtD
Ceftibuten—Dyspnoea—Sorafenib—kidney cancer	0.00185	0.00185	CcSEcCtD
Ceftibuten—Pancytopenia—Capecitabine—kidney cancer	0.00184	0.00184	CcSEcCtD
Ceftibuten—Dyspepsia—Sorafenib—kidney cancer	0.00183	0.00183	CcSEcCtD
Ceftibuten—Body temperature increased—Erlotinib—kidney cancer	0.00182	0.00182	CcSEcCtD
Ceftibuten—Abdominal pain—Erlotinib—kidney cancer	0.00182	0.00182	CcSEcCtD
Ceftibuten—Dysuria—Capecitabine—kidney cancer	0.00181	0.00181	CcSEcCtD
Ceftibuten—Neutropenia—Capecitabine—kidney cancer	0.00181	0.00181	CcSEcCtD
Ceftibuten—Insomnia—Sunitinib—kidney cancer	0.00181	0.00181	CcSEcCtD
Ceftibuten—Decreased appetite—Sorafenib—kidney cancer	0.00181	0.00181	CcSEcCtD
Ceftibuten—Anorexia—Dactinomycin—kidney cancer	0.0018	0.0018	CcSEcCtD
Ceftibuten—Nausea—Pazopanib—kidney cancer	0.0018	0.0018	CcSEcCtD
Ceftibuten—Paraesthesia—Sunitinib—kidney cancer	0.00179	0.00179	CcSEcCtD
Ceftibuten—Convulsion—Vincristine—kidney cancer	0.00179	0.00179	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Sorafenib—kidney cancer	0.00179	0.00179	CcSEcCtD
Ceftibuten—Fatigue—Sorafenib—kidney cancer	0.00179	0.00179	CcSEcCtD
Ceftibuten—Erythema multiforme—Paclitaxel—kidney cancer	0.00179	0.00179	CcSEcCtD
Ceftibuten—Dyspnoea—Sunitinib—kidney cancer	0.00178	0.00178	CcSEcCtD
Ceftibuten—Constipation—Sorafenib—kidney cancer	0.00178	0.00178	CcSEcCtD
Ceftibuten—Hypersensitivity—Vinblastine—kidney cancer	0.00177	0.00177	CcSEcCtD
Ceftibuten—Hypersensitivity—Everolimus—kidney cancer	0.00176	0.00176	CcSEcCtD
Ceftibuten—Dyspepsia—Sunitinib—kidney cancer	0.00176	0.00176	CcSEcCtD
Ceftibuten—Decreased appetite—Sunitinib—kidney cancer	0.00174	0.00174	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Sunitinib—kidney cancer	0.00173	0.00173	CcSEcCtD
Ceftibuten—Asthenia—Vinblastine—kidney cancer	0.00172	0.00172	CcSEcCtD
Ceftibuten—Fatigue—Sunitinib—kidney cancer	0.00172	0.00172	CcSEcCtD
Ceftibuten—Asthenia—Everolimus—kidney cancer	0.00172	0.00172	CcSEcCtD
Ceftibuten—Stevens-Johnson syndrome—Capecitabine—kidney cancer	0.00171	0.00171	CcSEcCtD
Ceftibuten—Constipation—Sunitinib—kidney cancer	0.00171	0.00171	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Sorafenib—kidney cancer	0.0017	0.0017	CcSEcCtD
Ceftibuten—Renal failure—Capecitabine—kidney cancer	0.0017	0.0017	CcSEcCtD
Ceftibuten—Chills—Paclitaxel—kidney cancer	0.0017	0.0017	CcSEcCtD
Ceftibuten—Pruritus—Everolimus—kidney cancer	0.00169	0.00169	CcSEcCtD
Ceftibuten—Anaphylactic shock—Vincristine—kidney cancer	0.00169	0.00169	CcSEcCtD
Ceftibuten—Jaundice—Capecitabine—kidney cancer	0.00168	0.00168	CcSEcCtD
Ceftibuten—Asthenia—Erlotinib—kidney cancer	0.00166	0.00166	CcSEcCtD
Ceftibuten—Urticaria—Sorafenib—kidney cancer	0.00165	0.00165	CcSEcCtD
Ceftibuten—Haematuria—Capecitabine—kidney cancer	0.00165	0.00165	CcSEcCtD
Ceftibuten—Decreased appetite—Dactinomycin—kidney cancer	0.00164	0.00164	CcSEcCtD
Ceftibuten—Diarrhoea—Vinblastine—kidney cancer	0.00164	0.00164	CcSEcCtD
Ceftibuten—Abdominal pain—Sorafenib—kidney cancer	0.00164	0.00164	CcSEcCtD
Ceftibuten—Body temperature increased—Sorafenib—kidney cancer	0.00164	0.00164	CcSEcCtD
Ceftibuten—Diarrhoea—Everolimus—kidney cancer	0.00164	0.00164	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Sunitinib—kidney cancer	0.00163	0.00163	CcSEcCtD
Ceftibuten—Pruritus—Erlotinib—kidney cancer	0.00163	0.00163	CcSEcCtD
Ceftibuten—Fatigue—Dactinomycin—kidney cancer	0.00163	0.00163	CcSEcCtD
Ceftibuten—Flatulence—Paclitaxel—kidney cancer	0.00162	0.00162	CcSEcCtD
Ceftibuten—Agranulocytosis—Capecitabine—kidney cancer	0.00161	0.00161	CcSEcCtD
Ceftibuten—Anorexia—Vincristine—kidney cancer	0.00161	0.00161	CcSEcCtD
Ceftibuten—Dysgeusia—Paclitaxel—kidney cancer	0.00161	0.00161	CcSEcCtD
Ceftibuten—Anaphylactic shock—Gemcitabine—kidney cancer	0.0016	0.0016	CcSEcCtD
Ceftibuten—Dizziness—Vinblastine—kidney cancer	0.00159	0.00159	CcSEcCtD
Ceftibuten—Dizziness—Everolimus—kidney cancer	0.00158	0.00158	CcSEcCtD
Ceftibuten—Abdominal pain—Sunitinib—kidney cancer	0.00158	0.00158	CcSEcCtD
Ceftibuten—Body temperature increased—Sunitinib—kidney cancer	0.00158	0.00158	CcSEcCtD
Ceftibuten—Diarrhoea—Erlotinib—kidney cancer	0.00158	0.00158	CcSEcCtD
Ceftibuten—Haemoglobin—Capecitabine—kidney cancer	0.00156	0.00156	CcSEcCtD
Ceftibuten—Haemorrhage—Capecitabine—kidney cancer	0.00155	0.00155	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Dactinomycin—kidney cancer	0.00155	0.00155	CcSEcCtD
Ceftibuten—Hypersensitivity—Sorafenib—kidney cancer	0.00153	0.00153	CcSEcCtD
Ceftibuten—Insomnia—Vincristine—kidney cancer	0.00153	0.00153	CcSEcCtD
Ceftibuten—Anorexia—Gemcitabine—kidney cancer	0.00153	0.00153	CcSEcCtD
Ceftibuten—Vomiting—Vinblastine—kidney cancer	0.00153	0.00153	CcSEcCtD
Ceftibuten—Dizziness—Erlotinib—kidney cancer	0.00153	0.00153	CcSEcCtD
Ceftibuten—Vomiting—Everolimus—kidney cancer	0.00152	0.00152	CcSEcCtD
Ceftibuten—Renal impairment—Doxorubicin—kidney cancer	0.00152	0.00152	CcSEcCtD
Ceftibuten—Paraesthesia—Vincristine—kidney cancer	0.00152	0.00152	CcSEcCtD
Ceftibuten—Agitation—Paclitaxel—kidney cancer	0.00151	0.00151	CcSEcCtD
Ceftibuten—Rash—Everolimus—kidney cancer	0.00151	0.00151	CcSEcCtD
Ceftibuten—Dermatitis—Everolimus—kidney cancer	0.00151	0.00151	CcSEcCtD
Ceftibuten—Headache—Vinblastine—kidney cancer	0.0015	0.0015	CcSEcCtD
Ceftibuten—Headache—Everolimus—kidney cancer	0.0015	0.0015	CcSEcCtD
Ceftibuten—Abdominal pain—Dactinomycin—kidney cancer	0.0015	0.0015	CcSEcCtD
Ceftibuten—Body temperature increased—Dactinomycin—kidney cancer	0.0015	0.0015	CcSEcCtD
Ceftibuten—Asthenia—Sorafenib—kidney cancer	0.00149	0.00149	CcSEcCtD
Ceftibuten—Hypersensitivity—Sunitinib—kidney cancer	0.00147	0.00147	CcSEcCtD
Ceftibuten—Decreased appetite—Vincristine—kidney cancer	0.00147	0.00147	CcSEcCtD
Ceftibuten—Pruritus—Sorafenib—kidney cancer	0.00147	0.00147	CcSEcCtD
Ceftibuten—Vomiting—Erlotinib—kidney cancer	0.00147	0.00147	CcSEcCtD
Ceftibuten—Erythema multiforme—Capecitabine—kidney cancer	0.00147	0.00147	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Vincristine—kidney cancer	0.00146	0.00146	CcSEcCtD
Ceftibuten—Fatigue—Vincristine—kidney cancer	0.00146	0.00146	CcSEcCtD
Ceftibuten—Rash—Erlotinib—kidney cancer	0.00146	0.00146	CcSEcCtD
Ceftibuten—Dermatitis—Erlotinib—kidney cancer	0.00145	0.00145	CcSEcCtD
Ceftibuten—Insomnia—Gemcitabine—kidney cancer	0.00145	0.00145	CcSEcCtD
Ceftibuten—Headache—Erlotinib—kidney cancer	0.00145	0.00145	CcSEcCtD
Ceftibuten—Constipation—Vincristine—kidney cancer	0.00145	0.00145	CcSEcCtD
Ceftibuten—Paraesthesia—Gemcitabine—kidney cancer	0.00144	0.00144	CcSEcCtD
Ceftibuten—Asthenia—Sunitinib—kidney cancer	0.00143	0.00143	CcSEcCtD
Ceftibuten—Dyspnoea—Gemcitabine—kidney cancer	0.00143	0.00143	CcSEcCtD
Ceftibuten—Nausea—Vinblastine—kidney cancer	0.00143	0.00143	CcSEcCtD
Ceftibuten—Somnolence—Gemcitabine—kidney cancer	0.00143	0.00143	CcSEcCtD
Ceftibuten—Convulsion—Paclitaxel—kidney cancer	0.00143	0.00143	CcSEcCtD
Ceftibuten—Nausea—Everolimus—kidney cancer	0.00142	0.00142	CcSEcCtD
Ceftibuten—Diarrhoea—Sorafenib—kidney cancer	0.00142	0.00142	CcSEcCtD
Ceftibuten—Pruritus—Sunitinib—kidney cancer	0.00141	0.00141	CcSEcCtD
Ceftibuten—Decreased appetite—Gemcitabine—kidney cancer	0.00139	0.00139	CcSEcCtD
Ceftibuten—Hypersensitivity—Dactinomycin—kidney cancer	0.00139	0.00139	CcSEcCtD
Ceftibuten—Chills—Capecitabine—kidney cancer	0.00139	0.00139	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.00138	0.00138	CcSEcCtD
Ceftibuten—Fatigue—Gemcitabine—kidney cancer	0.00138	0.00138	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Vincristine—kidney cancer	0.00138	0.00138	CcSEcCtD
Ceftibuten—Dizziness—Sorafenib—kidney cancer	0.00137	0.00137	CcSEcCtD
Ceftibuten—Constipation—Gemcitabine—kidney cancer	0.00137	0.00137	CcSEcCtD
Ceftibuten—Nausea—Erlotinib—kidney cancer	0.00137	0.00137	CcSEcCtD
Ceftibuten—Dry mouth—Paclitaxel—kidney cancer	0.00137	0.00137	CcSEcCtD
Ceftibuten—Diarrhoea—Sunitinib—kidney cancer	0.00137	0.00137	CcSEcCtD
Ceftibuten—Asthenia—Dactinomycin—kidney cancer	0.00136	0.00136	CcSEcCtD
Ceftibuten—Dehydration—Doxorubicin—kidney cancer	0.00134	0.00134	CcSEcCtD
Ceftibuten—Anaphylactic shock—Paclitaxel—kidney cancer	0.00134	0.00134	CcSEcCtD
Ceftibuten—Abdominal pain—Vincristine—kidney cancer	0.00134	0.00134	CcSEcCtD
Ceftibuten—Body temperature increased—Vincristine—kidney cancer	0.00134	0.00134	CcSEcCtD
Ceftibuten—Flatulence—Capecitabine—kidney cancer	0.00133	0.00133	CcSEcCtD
Ceftibuten—Dysgeusia—Capecitabine—kidney cancer	0.00132	0.00132	CcSEcCtD
Ceftibuten—Dizziness—Sunitinib—kidney cancer	0.00132	0.00132	CcSEcCtD
Ceftibuten—Vomiting—Sorafenib—kidney cancer	0.00132	0.00132	CcSEcCtD
Ceftibuten—Rash—Sorafenib—kidney cancer	0.00131	0.00131	CcSEcCtD
Ceftibuten—Dermatitis—Sorafenib—kidney cancer	0.00131	0.00131	CcSEcCtD
Ceftibuten—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	0.0013	0.0013	CcSEcCtD
Ceftibuten—Headache—Sorafenib—kidney cancer	0.0013	0.0013	CcSEcCtD
Ceftibuten—Diarrhoea—Dactinomycin—kidney cancer	0.00129	0.00129	CcSEcCtD
Ceftibuten—Anorexia—Paclitaxel—kidney cancer	0.00128	0.00128	CcSEcCtD
Ceftibuten—Vomiting—Sunitinib—kidney cancer	0.00127	0.00127	CcSEcCtD
Ceftibuten—Body temperature increased—Gemcitabine—kidney cancer	0.00127	0.00127	CcSEcCtD
Ceftibuten—Rash—Sunitinib—kidney cancer	0.00126	0.00126	CcSEcCtD
Ceftibuten—Dermatitis—Sunitinib—kidney cancer	0.00126	0.00126	CcSEcCtD
Ceftibuten—Headache—Sunitinib—kidney cancer	0.00125	0.00125	CcSEcCtD
Ceftibuten—Hypersensitivity—Vincristine—kidney cancer	0.00125	0.00125	CcSEcCtD
Ceftibuten—Nausea—Sorafenib—kidney cancer	0.00123	0.00123	CcSEcCtD
Ceftibuten—Insomnia—Paclitaxel—kidney cancer	0.00121	0.00121	CcSEcCtD
Ceftibuten—Asthenia—Vincristine—kidney cancer	0.00121	0.00121	CcSEcCtD
Ceftibuten—Paraesthesia—Paclitaxel—kidney cancer	0.00121	0.00121	CcSEcCtD
Ceftibuten—Vomiting—Dactinomycin—kidney cancer	0.0012	0.0012	CcSEcCtD
Ceftibuten—Dyspnoea—Paclitaxel—kidney cancer	0.0012	0.0012	CcSEcCtD
Ceftibuten—Somnolence—Paclitaxel—kidney cancer	0.00119	0.00119	CcSEcCtD
Ceftibuten—Rash—Dactinomycin—kidney cancer	0.00119	0.00119	CcSEcCtD
Ceftibuten—Nausea—Sunitinib—kidney cancer	0.00119	0.00119	CcSEcCtD
Ceftibuten—Pancytopenia—Doxorubicin—kidney cancer	0.00119	0.00119	CcSEcCtD
Ceftibuten—Dyspepsia—Paclitaxel—kidney cancer	0.00118	0.00118	CcSEcCtD
Ceftibuten—Dysuria—Doxorubicin—kidney cancer	0.00117	0.00117	CcSEcCtD
Ceftibuten—Neutropenia—Doxorubicin—kidney cancer	0.00117	0.00117	CcSEcCtD
Ceftibuten—Decreased appetite—Paclitaxel—kidney cancer	0.00117	0.00117	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.00116	0.00116	CcSEcCtD
Ceftibuten—Fatigue—Paclitaxel—kidney cancer	0.00116	0.00116	CcSEcCtD
Ceftibuten—Diarrhoea—Vincristine—kidney cancer	0.00116	0.00116	CcSEcCtD
Ceftibuten—Asthenia—Gemcitabine—kidney cancer	0.00115	0.00115	CcSEcCtD
Ceftibuten—Constipation—Paclitaxel—kidney cancer	0.00115	0.00115	CcSEcCtD
Ceftibuten—Pruritus—Gemcitabine—kidney cancer	0.00113	0.00113	CcSEcCtD
Ceftibuten—Dry mouth—Capecitabine—kidney cancer	0.00112	0.00112	CcSEcCtD
Ceftibuten—Nausea—Dactinomycin—kidney cancer	0.00112	0.00112	CcSEcCtD
Ceftibuten—Dizziness—Vincristine—kidney cancer	0.00112	0.00112	CcSEcCtD
Ceftibuten—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	0.0011	0.0011	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Paclitaxel—kidney cancer	0.0011	0.0011	CcSEcCtD
Ceftibuten—Diarrhoea—Gemcitabine—kidney cancer	0.0011	0.0011	CcSEcCtD
Ceftibuten—Renal failure—Doxorubicin—kidney cancer	0.00109	0.00109	CcSEcCtD
Ceftibuten—Jaundice—Doxorubicin—kidney cancer	0.00109	0.00109	CcSEcCtD
Ceftibuten—Vomiting—Vincristine—kidney cancer	0.00107	0.00107	CcSEcCtD
Ceftibuten—Urticaria—Paclitaxel—kidney cancer	0.00107	0.00107	CcSEcCtD
Ceftibuten—Rash—Vincristine—kidney cancer	0.00107	0.00107	CcSEcCtD
Ceftibuten—Dermatitis—Vincristine—kidney cancer	0.00106	0.00106	CcSEcCtD
Ceftibuten—Haematuria—Doxorubicin—kidney cancer	0.00106	0.00106	CcSEcCtD
Ceftibuten—Abdominal pain—Paclitaxel—kidney cancer	0.00106	0.00106	CcSEcCtD
Ceftibuten—Body temperature increased—Paclitaxel—kidney cancer	0.00106	0.00106	CcSEcCtD
Ceftibuten—Headache—Vincristine—kidney cancer	0.00106	0.00106	CcSEcCtD
Ceftibuten—Anorexia—Capecitabine—kidney cancer	0.00105	0.00105	CcSEcCtD
Ceftibuten—Agranulocytosis—Doxorubicin—kidney cancer	0.00104	0.00104	CcSEcCtD
Ceftibuten—Vomiting—Gemcitabine—kidney cancer	0.00102	0.00102	CcSEcCtD
Ceftibuten—Rash—Gemcitabine—kidney cancer	0.00101	0.00101	CcSEcCtD
Ceftibuten—Dermatitis—Gemcitabine—kidney cancer	0.00101	0.00101	CcSEcCtD
Ceftibuten—Haemoglobin—Doxorubicin—kidney cancer	0.001	0.001	CcSEcCtD
Ceftibuten—Headache—Gemcitabine—kidney cancer	0.001	0.001	CcSEcCtD
Ceftibuten—Nausea—Vincristine—kidney cancer	0.001	0.001	CcSEcCtD
Ceftibuten—Haemorrhage—Doxorubicin—kidney cancer	0.000999	0.000999	CcSEcCtD
Ceftibuten—Insomnia—Capecitabine—kidney cancer	0.000996	0.000996	CcSEcCtD
Ceftibuten—Paraesthesia—Capecitabine—kidney cancer	0.000989	0.000989	CcSEcCtD
Ceftibuten—Hypersensitivity—Paclitaxel—kidney cancer	0.000989	0.000989	CcSEcCtD
Ceftibuten—Dyspnoea—Capecitabine—kidney cancer	0.000982	0.000982	CcSEcCtD
Ceftibuten—Dyspepsia—Capecitabine—kidney cancer	0.00097	0.00097	CcSEcCtD
Ceftibuten—Asthenia—Paclitaxel—kidney cancer	0.000963	0.000963	CcSEcCtD
Ceftibuten—Decreased appetite—Capecitabine—kidney cancer	0.000958	0.000958	CcSEcCtD
Ceftibuten—Nausea—Gemcitabine—kidney cancer	0.000952	0.000952	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000951	0.000951	CcSEcCtD
Ceftibuten—Fatigue—Capecitabine—kidney cancer	0.00095	0.00095	CcSEcCtD
Ceftibuten—Pruritus—Paclitaxel—kidney cancer	0.00095	0.00095	CcSEcCtD
Ceftibuten—Erythema multiforme—Doxorubicin—kidney cancer	0.000945	0.000945	CcSEcCtD
Ceftibuten—Constipation—Capecitabine—kidney cancer	0.000942	0.000942	CcSEcCtD
Ceftibuten—Diarrhoea—Paclitaxel—kidney cancer	0.000918	0.000918	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Capecitabine—kidney cancer	0.000901	0.000901	CcSEcCtD
Ceftibuten—Chills—Doxorubicin—kidney cancer	0.000897	0.000897	CcSEcCtD
Ceftibuten—Dizziness—Paclitaxel—kidney cancer	0.000888	0.000888	CcSEcCtD
Ceftibuten—Urticaria—Capecitabine—kidney cancer	0.000875	0.000875	CcSEcCtD
Ceftibuten—Body temperature increased—Capecitabine—kidney cancer	0.000871	0.000871	CcSEcCtD
Ceftibuten—Abdominal pain—Capecitabine—kidney cancer	0.000871	0.000871	CcSEcCtD
Ceftibuten—Flatulence—Doxorubicin—kidney cancer	0.000857	0.000857	CcSEcCtD
Ceftibuten—Vomiting—Paclitaxel—kidney cancer	0.000853	0.000853	CcSEcCtD
Ceftibuten—Dysgeusia—Doxorubicin—kidney cancer	0.000852	0.000852	CcSEcCtD
Ceftibuten—Rash—Paclitaxel—kidney cancer	0.000846	0.000846	CcSEcCtD
Ceftibuten—Dermatitis—Paclitaxel—kidney cancer	0.000846	0.000846	CcSEcCtD
Ceftibuten—Headache—Paclitaxel—kidney cancer	0.000841	0.000841	CcSEcCtD
Ceftibuten—Hypersensitivity—Capecitabine—kidney cancer	0.000812	0.000812	CcSEcCtD
Ceftibuten—Agitation—Doxorubicin—kidney cancer	0.0008	0.0008	CcSEcCtD
Ceftibuten—Nausea—Paclitaxel—kidney cancer	0.000797	0.000797	CcSEcCtD
Ceftibuten—Asthenia—Capecitabine—kidney cancer	0.00079	0.00079	CcSEcCtD
Ceftibuten—Pruritus—Capecitabine—kidney cancer	0.000779	0.000779	CcSEcCtD
Ceftibuten—Convulsion—Doxorubicin—kidney cancer	0.000754	0.000754	CcSEcCtD
Ceftibuten—Diarrhoea—Capecitabine—kidney cancer	0.000754	0.000754	CcSEcCtD
Ceftibuten—Dizziness—Capecitabine—kidney cancer	0.000728	0.000728	CcSEcCtD
Ceftibuten—Dry mouth—Doxorubicin—kidney cancer	0.000724	0.000724	CcSEcCtD
Ceftibuten—Anaphylactic shock—Doxorubicin—kidney cancer	0.00071	0.00071	CcSEcCtD
Ceftibuten—Vomiting—Capecitabine—kidney cancer	0.0007	0.0007	CcSEcCtD
Ceftibuten—Rash—Capecitabine—kidney cancer	0.000695	0.000695	CcSEcCtD
Ceftibuten—Dermatitis—Capecitabine—kidney cancer	0.000694	0.000694	CcSEcCtD
Ceftibuten—Headache—Capecitabine—kidney cancer	0.00069	0.00069	CcSEcCtD
Ceftibuten—Anorexia—Doxorubicin—kidney cancer	0.000677	0.000677	CcSEcCtD
Ceftibuten—Nausea—Capecitabine—kidney cancer	0.000654	0.000654	CcSEcCtD
Ceftibuten—Insomnia—Doxorubicin—kidney cancer	0.000642	0.000642	CcSEcCtD
Ceftibuten—Paraesthesia—Doxorubicin—kidney cancer	0.000638	0.000638	CcSEcCtD
Ceftibuten—Dyspnoea—Doxorubicin—kidney cancer	0.000633	0.000633	CcSEcCtD
Ceftibuten—Somnolence—Doxorubicin—kidney cancer	0.000631	0.000631	CcSEcCtD
Ceftibuten—Dyspepsia—Doxorubicin—kidney cancer	0.000625	0.000625	CcSEcCtD
Ceftibuten—Decreased appetite—Doxorubicin—kidney cancer	0.000617	0.000617	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000613	0.000613	CcSEcCtD
Ceftibuten—Fatigue—Doxorubicin—kidney cancer	0.000612	0.000612	CcSEcCtD
Ceftibuten—Constipation—Doxorubicin—kidney cancer	0.000607	0.000607	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000581	0.000581	CcSEcCtD
Ceftibuten—Urticaria—Doxorubicin—kidney cancer	0.000564	0.000564	CcSEcCtD
Ceftibuten—Abdominal pain—Doxorubicin—kidney cancer	0.000561	0.000561	CcSEcCtD
Ceftibuten—Body temperature increased—Doxorubicin—kidney cancer	0.000561	0.000561	CcSEcCtD
Ceftibuten—Hypersensitivity—Doxorubicin—kidney cancer	0.000523	0.000523	CcSEcCtD
Ceftibuten—Asthenia—Doxorubicin—kidney cancer	0.000509	0.000509	CcSEcCtD
Ceftibuten—Pruritus—Doxorubicin—kidney cancer	0.000502	0.000502	CcSEcCtD
Ceftibuten—Diarrhoea—Doxorubicin—kidney cancer	0.000486	0.000486	CcSEcCtD
Ceftibuten—Dizziness—Doxorubicin—kidney cancer	0.00047	0.00047	CcSEcCtD
Ceftibuten—Vomiting—Doxorubicin—kidney cancer	0.000451	0.000451	CcSEcCtD
Ceftibuten—Rash—Doxorubicin—kidney cancer	0.000448	0.000448	CcSEcCtD
Ceftibuten—Dermatitis—Doxorubicin—kidney cancer	0.000447	0.000447	CcSEcCtD
Ceftibuten—Headache—Doxorubicin—kidney cancer	0.000445	0.000445	CcSEcCtD
Ceftibuten—Nausea—Doxorubicin—kidney cancer	0.000422	0.000422	CcSEcCtD
